These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21254638)

  • 21. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia.
    Roehrborn CG; Prajsner A; Kirby R; Andersen M; Quinn S; Mallen S
    Eur Urol; 2005 Sep; 48(3):445-52; discussion 452. PubMed ID: 15996811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of Vitaprost (tablets and rectal suppositories) for patients rehabilitation after invasive diagnostic urological interventions].
    Ergakov DV; Martov AG
    Urologiia; 2015 Dec; (6):20-25. PubMed ID: 28247675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
    Ichioka K; Ohara H; Terada N; Matsui Y; Yoshimura K; Terai A; Arai Y
    Int J Urol; 2004 Oct; 11(10):870-5. PubMed ID: 15479292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Administration of vitaprost plus for prevention of infectious-inflammatory complications of transurethral prostatic resection in patients with prostatic adenoma].
    Nozdrachev NA; Neĭmark AI; Neĭmark BA
    Urologiia; 2011; (4):55, 57-60. PubMed ID: 22066244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The efficacy of alfuzosin (dalfaz) in patients with benign prostatic hyperplasia].
    Tkachuk VN; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (2):38-40. PubMed ID: 9577703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expediency of switching from combined therapy with prostamol Uno and alpha-1-adrenoblockers to monotherapy with prostamol Uno in patients with prostatic adenoma].
    Razumov SV; Egorov AA
    Urologiia; 2007; (3):47-50. PubMed ID: 17724829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tadenan treatment of prostatic adenoma].
    Danilov VV; Elisseva EV; Vasil'chenko AV
    Urologiia; 2009; (2):68, 70-3. PubMed ID: 19526878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
    Chung BH; Hong SJ; Lee MS
    Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of treating lower urinary tract symptoms on health-related quality of life: a short-term outcome.
    Quek KF; Loh CS; Low WY; Razack AH; Chua CB
    Singapore Med J; 2002 Aug; 43(8):391-8. PubMed ID: 12507023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].
    Avdoshin VP; Pul'bere SA
    Urologiia; 2012; (2):44, 46-7. PubMed ID: 22876633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
    Noguchi K; Takeda M; Hosaka M; Kubota Y
    Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transurethral plasmokinetic resection and vaporization is a new method of treatment of prostatic adenoma].
    Martov AG; Merinov DS; Borisenko EA
    Urologiia; 2006; (3):12-3, 15-6. PubMed ID: 16889082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical effects of beta-sitosterol (phytosterol) on benign prostatic hyperplasia: preliminary study].
    Kobayashi Y; Sugaya Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):865-8. PubMed ID: 10028431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.